| Valacyclovir Hydrochloride |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Valbenazine Tosylate |
Capsule (Sprinkle) |
I (Basket) |
50 |
0.1 N HCl |
900 |
5, 15, 20, 30 and 45 |
2024/11/15 |
| Valbenazine Tosylate |
Capsule |
II (Paddle) with sinker |
50 |
Tier 1: 0.1N HCl; Tier 2: 0.1N HCl containing pepsin (750,000 units per 1000 mL) |
900 |
5, 10, 15, 20 and 30 |
2017/11/02 |
| Valganciclovir HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Valproic Acid |
Capsule |
|
|
Refer to USP |
|
|
2009/12/15 |
| Valsartan |
Tablet |
|
|
Refer to USP |
|
|
2016/07/28 |
| Valsartan |
Capsule |
II (Paddle) |
50 |
0.067 M Phosphate Buffer, pH 6.8 |
1000 |
10, 20, 30 and 45 |
2004/12/13 |
| Vamorolone |
Suspension |
II (Paddle) |
75 |
Phosphate Buffer, pH 6.8 w/ 0.5% SLS |
900 |
5, 10, 15, 20, 30, 45, 60 and 90 |
2025/06/23 |
| Vancomycin hydrochloride |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Vandetanib |
Tablet |
II (Paddle) |
50 |
pH 1.2 Buffer [0.05 M KCl in water, adjust the pH with HCl or NaOH] |
1000 |
5, 10, 15, 20 and 30 |
2015/06/25 |
| Vardenafil HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Vardenafil HCl |
Tablet (Orally Disintegrating) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
5, 10, 15 and 30 |
2014/05/15 |
| Varenicline Tartrate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Vemurafenib |
Tablet |
II (Paddle) |
75 |
1% hexadecyltrimethylammonium bromide (HTAB) in 0.05 M Phosphate Buffer, pH 6.8 |
900 |
10, 15, 20, 30 and 45 |
2015/05/28 |
| Venetoclax |
Tablet |
III (Reciprocating Cylinder) [Bottom Screen: 200 mesh stainless steel] |
20 dpm |
Phosphate Buffer, pH 6.8 with 0.4% sodium dodecyl sulfate (SDS) [3 small drops of antifoaming agent may be used] |
250 |
0.25, 0.5, 0.75, 1, 1.5, 2, 3, 3.5 and 4 hours |
2016/07/28 |
| Venlafaxine Besylate |
Tablet (Extended Release) |
II (Paddle with sinker) |
50 |
0.1 M NaCl in water (Degassed) |
900 |
1, 2, 4, 6, 8, 12, 14 and 16 hours |
2023/02/09 |
| Venlafaxine HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
| Venlafaxine HCl |
Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Venlafaxine HCl |
Capsule (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Verapamil HCl |
Tablet |
|
|
Refer to USP |
|
|
2008/11/04 |